Skip to main content
Erschienen in: Archives of Dermatological Research 7/2018

04.07.2018 | Concise Communication

Phenotype variability in tumor disorders of the skin appendages associated with mutations in the CYLD gene

verfasst von: Lizelotte J. M. T. Parren, Kathrin Giehl, Michel van Geel, Jorge Frank

Erschienen in: Archives of Dermatological Research | Ausgabe 7/2018

Einloggen, um Zugang zu erhalten

Abstract

Mutations in the tumor suppressor gene CYLD underlie phenotypically heterogeneous hereditary tumor disorders of the skin appendages. These diseases are inherited autosomal dominantly and include Brooke–Spiegler syndrome (BSS; OMIM 605041), familial cylindromatosis (FC; OMIM 132700) and multiple familial trichoepithelioma (MFT; OMIM 601606). Clinically, cylindromas, trichoepitheliomas and spiradenomas can be found in affected individuals. We sought to elucidate the molecular genetic basis in individuals with newly diagnosed cylindromas, trichoepitheliomas and/or spiradenomas. Mutation analysis using polymerase chain reaction (PCR)-based techniques was performed in seven German patients and one Turkish patient. We detected two missense, two nonsense, two deletions and two duplication mutations in the CYLD gene, of which seven have not yet been reported. No genotype–phenotype correlation was detected amongst the patients. Our data provide additional information on the clinical and molecular genetic heterogeneity of disorders associated with CYLD mutations.
Literatur
1.
Zurück zum Zitat Ancell H (1842) History of a remarkable case of tumours developed on the head and face; accompanied with a similar disease in the abdomen. Med Chir Trans 25:227–246CrossRefPubMedPubMedCentral Ancell H (1842) History of a remarkable case of tumours developed on the head and face; accompanied with a similar disease in the abdomen. Med Chir Trans 25:227–246CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Brooke H (1892) Epithelioma adenoids cysticum. Br J Dermatol Syph 10(1892):459–473 Brooke H (1892) Epithelioma adenoids cysticum. Br J Dermatol Syph 10(1892):459–473
3.
Zurück zum Zitat Fordyce J (1892) Multiple benign cystic epithelioma of the skin. J Cutan Dis 10:459–473 Fordyce J (1892) Multiple benign cystic epithelioma of the skin. J Cutan Dis 10:459–473
4.
Zurück zum Zitat Spiegler E (1899) Ueber endoteliome der haut. AMA Arch Dermatol Syph 50:163–176CrossRef Spiegler E (1899) Ueber endoteliome der haut. AMA Arch Dermatol Syph 50:163–176CrossRef
5.
Zurück zum Zitat Welch J, Wells R, Kerr C (1968) Ancell–Spiegler cylindromas (turban tumours) and Brooke–Fordyce trichoepitheliomas: evidence for a single genetic entity. J Med Genet 5:29–35CrossRefPubMedPubMedCentral Welch J, Wells R, Kerr C (1968) Ancell–Spiegler cylindromas (turban tumours) and Brooke–Fordyce trichoepitheliomas: evidence for a single genetic entity. J Med Genet 5:29–35CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Gottschalk HR (1974) Proceedings: dermal eccrine cylindromas, epithelioma adenoides cysticum of Brooke, and eccrine spiradenoma. Arch Dermatol 110:473–474CrossRefPubMed Gottschalk HR (1974) Proceedings: dermal eccrine cylindromas, epithelioma adenoides cysticum of Brooke, and eccrine spiradenoma. Arch Dermatol 110:473–474CrossRefPubMed
7.
Zurück zum Zitat Sellheyer K (2015) Spiradenoma and cylindroma originate from the hair follicle bulge and not from the eccrine sweat gland: an immunohistochemical study with CD200 and other stem cell markers. J Cutan Pathol 42:90–101CrossRefPubMed Sellheyer K (2015) Spiradenoma and cylindroma originate from the hair follicle bulge and not from the eccrine sweat gland: an immunohistochemical study with CD200 and other stem cell markers. J Cutan Pathol 42:90–101CrossRefPubMed
8.
Zurück zum Zitat Nyame TT, Mattos D, Lian CG, Granter SR, Laga AC, Caterson EJ (2015) Malignant eccrine spiradenoma of the face. J Craniofac Surg 26:1711–1712CrossRefPubMed Nyame TT, Mattos D, Lian CG, Granter SR, Laga AC, Caterson EJ (2015) Malignant eccrine spiradenoma of the face. J Craniofac Surg 26:1711–1712CrossRefPubMed
9.
Zurück zum Zitat Samaka RM, Bakry OA, Seleit I, Abdelwahed MM, Hassan RA (2013) Multiple familial trichoepithelioma with malignant transformation. Indian J Dermatol 58:409PubMedPubMedCentral Samaka RM, Bakry OA, Seleit I, Abdelwahed MM, Hassan RA (2013) Multiple familial trichoepithelioma with malignant transformation. Indian J Dermatol 58:409PubMedPubMedCentral
10.
Zurück zum Zitat Tripath SM, Somu TN, Sundaram M, Sahiya S (2015) Malignant cylindroma of post aural region involving the temporal bone. J Clin Diagn Res 9:MD01–MD02 Tripath SM, Somu TN, Sundaram M, Sahiya S (2015) Malignant cylindroma of post aural region involving the temporal bone. J Clin Diagn Res 9:MD01–MD02
11.
Zurück zum Zitat Biggs PJ, Wooster R, Ford D, Chapman P, Mangion J, Quirk Y, Easton DF, Burn J, Stratton MR (1995) Familial cylindromatosis (turban tumour syndrome) gene localized to chromosome 16q12-13: evidence for its role as a tumour suppressor gene. Nat Genet 11:441–443CrossRefPubMed Biggs PJ, Wooster R, Ford D, Chapman P, Mangion J, Quirk Y, Easton DF, Burn J, Stratton MR (1995) Familial cylindromatosis (turban tumour syndrome) gene localized to chromosome 16q12-13: evidence for its role as a tumour suppressor gene. Nat Genet 11:441–443CrossRefPubMed
12.
Zurück zum Zitat Bignell GR, Warren W, Seal S, Takahashi M, Rapley E, Barfoot R, Green H, Brown C, Biggs PJ, Lakhani SR, Jones C, Hansen J, Blair E, Hofmann B, Siebert R, Turner G, Evans DG, Schrander-Stumpel C, Beemer FA, van den Ouweland A, Halley D, Delpech B, Cleveland MG, Leigh I, Leisti J, Rasmussen S (2000) Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet 25:160–165CrossRefPubMed Bignell GR, Warren W, Seal S, Takahashi M, Rapley E, Barfoot R, Green H, Brown C, Biggs PJ, Lakhani SR, Jones C, Hansen J, Blair E, Hofmann B, Siebert R, Turner G, Evans DG, Schrander-Stumpel C, Beemer FA, van den Ouweland A, Halley D, Delpech B, Cleveland MG, Leigh I, Leisti J, Rasmussen S (2000) Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet 25:160–165CrossRefPubMed
13.
Zurück zum Zitat Blake PW, Toro JR (2009) Update of cylindromatosis gene (CYLD) mutations in Brooke–Spiegler syndrome: novel insights into the role of deubiquitination in cell signalling. Hum Mutat 30:1025–1036CrossRefPubMedPubMedCentral Blake PW, Toro JR (2009) Update of cylindromatosis gene (CYLD) mutations in Brooke–Spiegler syndrome: novel insights into the role of deubiquitination in cell signalling. Hum Mutat 30:1025–1036CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Sporing Harbor Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Sporing Harbor
15.
Zurück zum Zitat Ewing B, Hillier L, Wendl MC, Green P (1998) Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res 8:175–185CrossRefPubMed Ewing B, Hillier L, Wendl MC, Green P (1998) Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res 8:175–185CrossRefPubMed
16.
Zurück zum Zitat Gordon D, Abajian C, Green P (1998) Consed: a graphical tool for sequence finishing. Genome Res 8:195–202CrossRefPubMed Gordon D, Abajian C, Green P (1998) Consed: a graphical tool for sequence finishing. Genome Res 8:195–202CrossRefPubMed
17.
Zurück zum Zitat Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, ACMG Laboratory Quality Assurance Committee (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–424CrossRefPubMedPubMedCentral Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, ACMG Laboratory Quality Assurance Committee (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–424CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Wallis Y, Payne S, McAnulty C, Bodmer D, Sistermans E, Robertson K, Moore D, Abbs S, Deans Z, Devereau A (2013) Practice guidelines for the evaluation of pathogenicity and the reporting of sequence variants in clinical molecular medicine. Association for Clinical Genetic Science (ACGS), Dutch Society of Clinical Laboratory Specialists (VKGL), Utrecht Wallis Y, Payne S, McAnulty C, Bodmer D, Sistermans E, Robertson K, Moore D, Abbs S, Deans Z, Devereau A (2013) Practice guidelines for the evaluation of pathogenicity and the reporting of sequence variants in clinical molecular medicine. Association for Clinical Genetic Science (ACGS), Dutch Society of Clinical Laboratory Specialists (VKGL), Utrecht
19.
Zurück zum Zitat Almeida S, Maillard C, Itin P, Hohl D, Huber M (2008) Five new CYLD mutations in skin appendage tumors and evidence that aspartic acid 681 in CYLD is essential for deubiquitinase activity. J Invest Dermatol 128:587–593CrossRefPubMed Almeida S, Maillard C, Itin P, Hohl D, Huber M (2008) Five new CYLD mutations in skin appendage tumors and evidence that aspartic acid 681 in CYLD is essential for deubiquitinase activity. J Invest Dermatol 128:587–593CrossRefPubMed
21.
Zurück zum Zitat Nagy N, Farkas K, Kemeny L, Szell M (2015) Phenotype-genotype correlations for clinical variants caused by CYLD mutations. Eur J Med Genet 58:271–278CrossRefPubMed Nagy N, Farkas K, Kemeny L, Szell M (2015) Phenotype-genotype correlations for clinical variants caused by CYLD mutations. Eur J Med Genet 58:271–278CrossRefPubMed
22.
Zurück zum Zitat Guardoli D, Arganziano G, Ponti G, Nasti S, Zalaudek I, Moscarella E, Lallas A, Piana S, Specchio F, Martinuzzi C, Raucci M, Pellacani G, Longo C (2015) A novel CYLD germline mutation in Brooke-Spiegler syndrome. J Eur Acad Dermatol Venereol 29:457–462CrossRefPubMed Guardoli D, Arganziano G, Ponti G, Nasti S, Zalaudek I, Moscarella E, Lallas A, Piana S, Specchio F, Martinuzzi C, Raucci M, Pellacani G, Longo C (2015) A novel CYLD germline mutation in Brooke-Spiegler syndrome. J Eur Acad Dermatol Venereol 29:457–462CrossRefPubMed
23.
Zurück zum Zitat Rajan N, Ashworth A (2015) Inherited cylindromas: lessons from a rare tumour. Lancet Oncol 16:e460–e469CrossRefPubMed Rajan N, Ashworth A (2015) Inherited cylindromas: lessons from a rare tumour. Lancet Oncol 16:e460–e469CrossRefPubMed
24.
Zurück zum Zitat Tancheva-Poor I, Vanecek T, Lurati MC, Rychly B, Kempf W, Michal M, Kazakov DV (2016) Report of three novel germline CYLD mutations in unrelated patients with Brooke-Spiegler syndrome, including classic phenotype, multiple familial trichoepitheliomas and malignant transformation. Dermatology 232:30–37CrossRef Tancheva-Poor I, Vanecek T, Lurati MC, Rychly B, Kempf W, Michal M, Kazakov DV (2016) Report of three novel germline CYLD mutations in unrelated patients with Brooke-Spiegler syndrome, including classic phenotype, multiple familial trichoepitheliomas and malignant transformation. Dermatology 232:30–37CrossRef
25.
Zurück zum Zitat Nasti S, Pastorino L, Bruno W (2009) Five novel germline function impairing mutations of CYLD in Italian patients with multiple cylindromas. Clin Genet 76:481–485CrossRefPubMed Nasti S, Pastorino L, Bruno W (2009) Five novel germline function impairing mutations of CYLD in Italian patients with multiple cylindromas. Clin Genet 76:481–485CrossRefPubMed
26.
Zurück zum Zitat Karousis ED, Nasif S, Muhlemann O (2016) Nonsense-mediated mRNA decay: novel mechanistic insights and biological impact. Wiley Interdiscip Rev RNA 7:661–682CrossRefPubMed Karousis ED, Nasif S, Muhlemann O (2016) Nonsense-mediated mRNA decay: novel mechanistic insights and biological impact. Wiley Interdiscip Rev RNA 7:661–682CrossRefPubMed
28.
Zurück zum Zitat Oiso N, Mizuno N, Fukai K, Nakagawa K, Ishii M (2004) Mild phenotype of familial cylindromatosis associated with an R758X nonsense mutation in the CYLD tumour suppressor gene. Br J Dermatol 15:1084–1086CrossRef Oiso N, Mizuno N, Fukai K, Nakagawa K, Ishii M (2004) Mild phenotype of familial cylindromatosis associated with an R758X nonsense mutation in the CYLD tumour suppressor gene. Br J Dermatol 15:1084–1086CrossRef
29.
Zurück zum Zitat Zhang G, Huang Y, Yan K, Li W, Fan X, Liang Y, Sun L, Li H, Zhang S, Gao M, Du W, Yang S, Liu J, Zhang X (2006) Diverse phenotype of Brooke–Spiegler syndrome associated with a nonsense mutation in the CYLD tumor suppressor gene. Exp Dermatol 15:966–970CrossRefPubMed Zhang G, Huang Y, Yan K, Li W, Fan X, Liang Y, Sun L, Li H, Zhang S, Gao M, Du W, Yang S, Liu J, Zhang X (2006) Diverse phenotype of Brooke–Spiegler syndrome associated with a nonsense mutation in the CYLD tumor suppressor gene. Exp Dermatol 15:966–970CrossRefPubMed
30.
Zurück zum Zitat Iliopoulos D, Jaeger SA, Hirsch HA, Bulyk ML, Struhl K (2010) STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell 39:493–506CrossRefPubMedPubMedCentral Iliopoulos D, Jaeger SA, Hirsch HA, Bulyk ML, Struhl K (2010) STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell 39:493–506CrossRefPubMedPubMedCentral
31.
32.
Zurück zum Zitat Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415–428CrossRefPubMed Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415–428CrossRefPubMed
Metadaten
Titel
Phenotype variability in tumor disorders of the skin appendages associated with mutations in the CYLD gene
verfasst von
Lizelotte J. M. T. Parren
Kathrin Giehl
Michel van Geel
Jorge Frank
Publikationsdatum
04.07.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Dermatological Research / Ausgabe 7/2018
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-018-1848-2

Weitere Artikel der Ausgabe 7/2018

Archives of Dermatological Research 7/2018 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.